Related references
Note: Only part of the references are listed.Anti-acne drugs in phase 1 and 2 clinical trials
Christos C. Zouboulis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Reduction of Inflammatory and Noninflammatory Lesions with Topical Tyrothricin 0.1% in the Treatment of Mild to Severe Acne Papulopustulosa: A Randomized Controlled Clinical Trial
Claudia Richter et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2016)
Dietary glycemic factors, insulin resistance, and adiponectin levels in acne vulgaris
Asli Aksu Cerman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
The Formulation of Bacteriophage in a Semi Solid Preparation for Control of Propionibacterium acnes Growth
Teagan L. Brown et al.
PLOS ONE (2016)
The epidemiology of acne vulgaris in late adolescence
Darren D. Lynn et al.
ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS (2016)
What's new in the physiopathology of acne?
D. H. Suh et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
A new antibiotic with potent activity targets MscL
Irene Iscla et al.
JOURNAL OF ANTIBIOTICS (2015)
Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response
Min Qin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes
Nathan W. Schmidt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Activity-Guided Purification Identifies Lupeol, a Pentacyclic Triterpene, As a Therapeutic Agent Targeting Multiple Pathogenic Factors of Acne
Hyuck Hoon Kwon et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
From new findings in acne pathogenesis to new approaches in treatment
H. P. M. Gollnick
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
Bodo C. Melnik
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2015)
p38 MAP Kinase Inhibition Reduces Propionibacterium acnes-Induced Inflammation in Vitro
Wen-Hwa Li et al.
DERMATOLOGY AND THERAPY (2015)
Novel pharmacological approaches for the treatment of acne vulgaris
Isabel Cristina Valente Duarte de Sousa
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
A genome-wide association study of severe teenage acne in European Americans
Mingfeng Zhang et al.
HUMAN GENETICS (2014)
Propionibacterium acnes: an update on its role in the pathogenesis of acne
C. Beylot et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
TNF-308 G/A Polymorphism and Risk of Acne Vulgaris: A Meta-Analysis
Jian-Kang Yang et al.
PLOS ONE (2014)
IL-17/Th17 Pathway Is Activated in Acne Lesions
Hanna-Leena Kelhala et al.
PLOS ONE (2014)
Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgaris
Alexander A. Navarini et al.
NATURE COMMUNICATIONS (2014)
Two new susceptibility loci 1q24.2 and 11p11.2 confer risk to severe acne
Li He et al.
NATURE COMMUNICATIONS (2014)
Safety and Efficacy of Intradermal Injection of Botulinum Toxin for the Treatment of Oily Skin
Amy E. Rose et al.
DERMATOLOGIC SURGERY (2013)
Regulation of lipid production by acetylcholine signalling in human sebaceous glands
Zheng Jun Li et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2013)
Insulin-like growth factor-I gene polymorphism in acne vulgaris
L Tasli et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Expression of inflammatory biomarkers from cultured sebocytes was influenced by treatment with vitamin D
WeonJu Lee et al.
INDIAN JOURNAL OF DERMATOLOGY (2013)
Role of Rifampin against Propionibacterium acnes Biofilm In Vitro and in an Experimental Foreign-Body Infection Model
Ulrika Furustrand Tafin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study
A. C. Jahns et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Epigallocatechin-3-Gallate Suppresses IGF-I-Induced Lipogenesis and Cytokine Expression in SZ95 Sebocytes
Myung Im et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1 beta-mediated diseases
Alexander M. Owyang et al.
MABS (2011)
Making the Case for Early Treatment of Acne
Andrea L. Zaenglein
CLINICAL PEDIATRICS (2010)
Zileuton, a new efficient and safe systemic anti-acne drug
Christos C. Zouboulis
DERMATO-ENDOCRINOLOGY (2009)
Sebum analysis of individuals with and without acne
Apostolos Pappas et al.
DERMATO-ENDOCRINOLOGY (2009)
Oral R115866 in the treatment of moderate to severe facial acne vulgaris: an exploratory study
C. J. Verfaille et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Induction of toll-like receptors by Propionibacterium acnes
S Jugeau et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Identification of novel inhibitors of bacterial translation elongation factors
MMK Jayasekera et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P-acnes GroEL
GM Graham et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Microbiology's principle of biofilms as a major factor in the pathogenesis of acne vulgaris
CN Burkhart et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2003)
Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses
J Kim et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
